Market revenue in 2023 | USD 105.8 million |
Market revenue in 2030 | USD 142.0 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Rapid Testing Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Rapid Testing Devices, Services |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug testing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 36.11% in 2024. Horizon Databook has segmented the Mexico drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
In Mexico, the regulation of drug testing falls under the jurisdiction of the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) and the Ministry of Health. COFEPRIS requires that all pharmaceutical products, medical devices, and other health-related products undergo testing before they can be approved for use in the country.
The testing is required to follow international standards, including those set by the Organization for Economic Cooperation and Development (OECD) and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
In Mexico, several private and public institutions offer drug testing services, including CROs and academic institutions. The market is becoming increasingly competitive, with both domestic and international companies seeking to expand their operations in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico drug testing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico drug testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account